Tech Company Financing Transactions
Retham Technologies Funding Round
Retham Technologies secured a $1.5 million Seed funding round on 9/15/2026. Investors included Talents Fund and Golden Angels Investors.
Transaction Overview
Company Name
Announced On
9/15/2026
Transaction Type
Venture Equity
Amount
$1,500,000
Round
Seed
Investors
Talents Fund (Lead Investor)
Proceeds Purpose
The company intends to use the funds to advance HITDx through clinical validation, FDA 510(k) clearance activities, and commercial readiness.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1225 Discovery Pkwy
Wauwatosa, WI 53226
USA
Wauwatosa, WI 53226
USA
Phone
Undisclosed
Website
Email Address
Overview
Retham Technologies, Inc.� was established in 2017 to translate recent discoveries into a life-saving in vitro diagnostic (IVD) assay that provides earlier and more accurate in-hospital diagnosis of Heparin-induced Thrombocytopenia (HIT). Retham Technologies� is developing HITDx�, an IVD assay for early and accurate near-patient HIT diagnosis that is expected to facilitate timely and appropriate therapy thereby leading to better outcomes.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Steven Visuri
Browse more venture capital transactions:
Prev: 9/15/2026: Decimal AI venture capital transaction
Next: 9/15/2026: RobotPlusPlus venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to document every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs